Drug resistance in pathogenic African trypanosomes: What hopes for the future?

Veterinary Parasitology

Volumn 96, Issue 2, 2001, Pages 83-100

  Anene, B M ^a   Onah, D N ^b   Nawa, Y ^b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Drug resistance; Trypanocides; Trypanosomes spp.

Indexed keywords

ANTITRYPANOSOMAL AGENT; DIMINAZENE ACETURATE; ETHIDIUM BROMIDE; ISOMETAMIDIUM; QUINAPYRAMINE;

AFRICAN TRYPANOSOMIASIS; ANTIBIOTIC RESISTANCE; ANTIGENIC VARIATION; ARTICLE; CHEMOTHERAPY; CROSS RESISTANCE; DRUG STRUCTURE; INFECTION CONTROL; NONHUMAN; PROPHYLAXIS; TREATMENT PLANNING; TSETSE FLY; VACCINATION; VECTOR CONTROL;

ANIMALS; DISEASE MANAGEMENT; DRUG RESISTANCE; MODELS, CHEMICAL; RESEARCH; TRYPANOCIDAL AGENTS; TRYPANOSOMA; TRYPANOSOMIASIS;

ANIMALIA;

EID: 0035916983     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(00)00427-1     Document Type: Article

References (99)

1. Combination therapy of trypanosomiasis using diminazene and non-steroidal anti-inflammatory drug
2. Isolation of drug-resistant strain of Trypanosoma congolense from the lower Shambelle region of southern Somalia
3. Approach of effective chemotherapy and chemoprophylaxis of animal trypanosomiasis in Nigeria
4. Isometamidium dextran complex: Therapeutic activity against Trypanosoma vivax infection in Zebu cattle
5. Diminazene/Berenil: Bioavailability and disposition in dairy goats
6. Clinical deafness associated with relapsing Trypanosoma brucei infection in a dog: A case report
7. Effects of DFMO alone and in combination with levamisole in the treatment of experimental Trypanosoma congolense infections of rats
8. Trypanocidal resistance in Trypanosoma evansi in vitro: Effects of verapamil, cyproheptadine, combination with trypanocides
9. Treatment of human trypanosomiasis
10. Lysis of trypanosomes by peptidylfluoromethyl ketones
11. Resistance to clinical drugs in African trypanosomes
12. Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and D,L-α-difluoromethylornithine: Reversal by polyamines
13. The biochemical basis of arsenical-diamidine cross-resistance in African trypanosomes
14. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity
15. Effect of stage of infection with Trypanosoma evansi on cymelarsan therapy
16. Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by berenil, pentamidine and methylglyoxal bis (quanylthydrazene)
17. In vitro activity of the trypanocidal diamidine DAPI on animal-infective Trypanosoma brucei brucei
18. Arsenical resistant trypanosomes lack an unusual adenosine transporter
19. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei
20. Therapeutic effect of Berenil and Samorin in mice with four Trypanosoma populations isolated from Zambian cattle
21. Trypanosoma congolense: Manifestation of resistance to Berenil and Samorin in cloned trypanosomes isolated from Zambian cattle
22. Relapse infection after chemotherapy in dogs experimentally infected with Trypanosoma brucei brucei
23. Efficacy of DFMO+bleomycin in a mouse model of central nervous system African trypanosomiasis
24. A new drug combination for experimental late stage African trypanosomiasis: DFMO with suramin
25. Development of multiple drug resistance of Trypanosoma congolense in Zebu cattle under high natural tsetse fly challenge in the pastoral zone of Samorogouan, Burkina Faso
26. Epidemiolgoy of bovine trypanosomiasis in the Ghibe valley, southwest Ethiopia. 3. Occurrence of populations of Trypanosoma congolense resistant to diminazene, isometamidium and homidium
27. Parasite proteinasaes and amino acid metabolism: Possibilities for chemotherapeutic exploitation
28. Pentamidine transport and sensitivity in brucei-group trypanosomes
29. Chimioprophylaxie antitrypanosomieme de bovins N'dama importes de Senegambie et du Zaire au Gabon
30. Adenosine transporter in bloodstream forms of Trypanosoma brucei brucei: Substrate recognition motifs and affinity for trypanocidal drugs
31. Parasite, animal production and sustainable development
32. Notes on the routine intravenous use of isometamidium in the control of bovine trypanosomiasis on the Kenya coast
33. Drug resistance in Sudanese Trypanosoma evansi
34. Characterization of melarsen resistant Trypanosoma brucei brucei with respect to other drugs and trypanothione metabolism
35. The therapeutic and prophylactic properties of antrycide in trypanosomiasis of cattle
36. Flow cytofluorimetric analysis of drug accumulation by multidrug-resistant Trypanosoma brucei brucei and T. b. rhodesiense
37. Chemotherapy against animal trypanosomiasis
38. Characterization of different proteolytic activities in Trypanosoma brucei brucei
39. Chemotherapy of trypanosomiasis
40. Trypanosomiasis
41. Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis
42. Chemotherapy of CNS trypanosomiasis: The combined use of diminazene aceturate or pentamidine with difluoromethylornithine (DFMO)
43. Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei
44. Combined Berenil and mepyramine maleate in the treatment of Berenil-resistant Trypanosoma vivax infections in sheep
45. Studies on the chemotherapeutic control of animal trypanosomiasis in Nigeria
46. Pharmacology of existing drugs for animal trypanosomiasis
47. Trypanosomiasis of camels in the Anglo-Egyptian Sudan: Diagnosis, chemotherapy, immunity
48. Perspectives in research and control of African trypanosomiasis
49. Present status of chemotherapy and chemoprophylaxis of animal trypanosomiasis in the eastern hemisphere
50. Characterization of cysteine protease from bloodstream forms of Trypanosoma congolense
51. Difluoromethylornithine and the rational development of polyamine antagonists for the cure of protozoan infection
52. Multiple drug-resistant bovine trypanosomiasis in South Darfur Province Sudan
53. Expression of resistance to isometamidium and diminazene in Trypanosoma congolense in Boran cattle infected by Glossina morsitans centralis
54. Efficacy of chemoprophylaxis for East African Zebu cattle exposed to trypanosomiasis in village herds in Kenya
55. Current public health status of the trypanosomiasis and leishmaniasis
56. Long-term occurrence of Trypanosoma congolense resistant to diminazene, isometamidium and homidium in cattle at G hibe, Ethiopia
57. Occurrence of berenil resistant strains of T. vivax
58. Derivation and characterization of a quinapyramine-resistant clone of Trypanosoma congolense
59. Mechanisms of action of phenanthridines and aminoquinaldine trypanocides
60. Multiple drug resistance in Trypanosoma vivax in Kenya
61. The chemotherapeutic efficacy of diminazene aceturate and lithium chloride against relapse infection of Trypanosoma brucei brucei in rats
62. The effects of hyperosmolar agents lithium chloride and sucrose on the brain concentration of diminazene aceturate in rats
63. Porcine cerebral Trypanosoma brucei brucei trypanosomosis
64. Proliferative responses of peripheral blood leucocytes of sheep infected with Trypanosoma evansi
65. Changes in peripheral blood lymphocyte subpopulations and parasite-specific antibody responses in Trypanosoma evansi infection of sheep
66. The rapid development of drug resistance by Trypanosoma evansi in immunosuppressed mice
67. Experimental infection of Friesian Holstein calves with an Indonesian isolate of Trypanosoma evansi
68. Efficacy of Cymelarsan treatment of suramin resistant Trypanosoma evansi in cattle
69. Chemotherapy and delivery systems: Haemoparasites
70. Pharmacology of diminazene: A review
71. Variation in resistance to isometamidium chloride and diminazene aceturate by clones derived from a stock of Trypanosoma congolense
72. Cross-resistance associated with development of resistance to isometamedium in a clone of Trypanosoma congolense
73. Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei
74. A review of cymelarsan: A new treatment proposed for animal trypanosomiasis due to Trypanosoma evansi and other trypanosomes of the T. brucei group
75. Alteration to one of three adenosine transporters is associated with resistance to cymelarsan in Trypanosoma evansi
76. Multiple drug resistance in Trypanosoma vivax in the Tana River District of Kenya
77. Maintenance of a herd of breeding cattle in an area of trypanosome challenge
78. Treatment of camels for Trypanosoma brucei evansi infection (Surra)
79. The sensitivity of trypanocidal drugs of Trypanosoma vivax isolated in Kenya and Somalia
80. 2
81. Studies on efficacy of repeat trypanocidal drug treatment against drug-resistant Trypanosoma congolense infections
82. Reduced accumulation of isometamidium by drug-resistant Trypanosoma congolense
83. Transport of isometamidium (samorin) by drug-resistant and drug-sensitive Trypanosoma congolense
84. Proteases from Trypanosoma brucei brucei: Purification, characterization and interaction with host regulatory molecules
85. Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei
86. Observations on antrycide-fast strains of Trypanosoma congolense and T. vivax
87. Treatment of Gambian sleeping sickness in the Sudan with oral DFMO (D,L-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial
88. Molecular mechanisms and chemotherapeutic approaches to the treatment of African trypanosomiasis
89. The maintenance of cattle in tsetse-infested country. A summary of four years' experience in Kenya
90. Recent work in Kenya on the control of drug-resistant cattle trypanosomiasis
91. The control of cattle trypanosomiasis with drugs in Kenya: Methods and costs
92. Review of chemotherapeutic and chemoprophylactic agents
93. Drug synergy in experimental African trypanosomiasis
94. Drug-resistance shown by trypanosomes following Antrycide treatment
95. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, Mel Cy, quinapyramine and isometamidium
96. Trypanosoma evansi: In vivo and in vitro determination of trypanocide resistance profiles
97. Evaluation of an arsenical compound (RM 110, Mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei and T. b. evansi
98. The treatment of Trypanosoma (Nannomonas) simiae in pigs with diminazene aceturate in combination with a 5-substituted 2-nitroimidazole compound (RO 15-0216)